Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerald P Radich

Showing results (121-130 of 208) with videos related to

Pageof 21
Sort By:
Blood|April 17, 2009
Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-upHagop Kantarjian, Jorge Cortes, Dong-Wook Kim, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemiaLaura W Dillon, Jake Higgins, Hassan Nasif, et al.
Science Translational Medicine|October 23, 2024
Characterization of clonal dynamics using duplex sequencing in donor-recipient pairs decades after hematopoietic cell transplantationMasumi Ueda Oshima, Jacob Higgins, Isaac Jenkins, et al.
British Journal of Haematology|November 30, 2010
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemiaAnjali S Advani, Holly M Gundacker, Olga Sala-Torra, et al.
Haematologica|August 3, 2023
Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemiaLaura W Dillon, Jake Higgins, Hassan Nasif, et al.
Clinical Chemistry|July 31, 2007
Development of an integrated assay for detection of BCR-ABL RNAEmily S Winn-Deen, Bret Helton, Reuel Van Atta, et al.
Genes, Chromosomes & Cancer|October 3, 2007
Identification of genes with abnormal expression changes in acute myeloid leukemiaDerek L Stirewalt, Soheil Meshinchi, Kenneth J Kopecky, et al.
Scientific Reports|March 29, 2020
Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemiaAndrew P Michelson, Shannon McDonough, Cheryl L Willman, et al.
Blood|February 27, 2008
DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cellsKellie V Rosinski, Nobuharu Fujii, Jeffrey K Mito, et al.
Blood|July 24, 2009
The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cellsVivian G Oehler, Katherine A Guthrie, Carrie L Cummings, et al.
Pageof 21

Showing results (121-130 of 208) with videos related to

Sort By:
Pageof 21
Blood|April 17, 2009
Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-upHagop Kantarjian, Jorge Cortes, Dong-Wook Kim, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemiaLaura W Dillon, Jake Higgins, Hassan Nasif, et al.
Science Translational Medicine|October 23, 2024
Characterization of clonal dynamics using duplex sequencing in donor-recipient pairs decades after hematopoietic cell transplantationMasumi Ueda Oshima, Jacob Higgins, Isaac Jenkins, et al.
British Journal of Haematology|November 30, 2010
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemiaAnjali S Advani, Holly M Gundacker, Olga Sala-Torra, et al.
Haematologica|August 3, 2023
Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemiaLaura W Dillon, Jake Higgins, Hassan Nasif, et al.
Clinical Chemistry|July 31, 2007
Development of an integrated assay for detection of BCR-ABL RNAEmily S Winn-Deen, Bret Helton, Reuel Van Atta, et al.
Genes, Chromosomes & Cancer|October 3, 2007
Identification of genes with abnormal expression changes in acute myeloid leukemiaDerek L Stirewalt, Soheil Meshinchi, Kenneth J Kopecky, et al.
Scientific Reports|March 29, 2020
Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemiaAndrew P Michelson, Shannon McDonough, Cheryl L Willman, et al.
Blood|February 27, 2008
DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cellsKellie V Rosinski, Nobuharu Fujii, Jeffrey K Mito, et al.
Blood|July 24, 2009
The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cellsVivian G Oehler, Katherine A Guthrie, Carrie L Cummings, et al.
Pageof 21